Psilocybin therapy for advanced cancer and depression
Treatments studied
Part of Blood & lymphatic, Cancer, Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This study tests whether a therapy combining psilocybin (a psychedelic substance) with counseling can help improve emotional well-being in people with advanced cancer who have symptoms of depression. It aims to see if this approach can ease suffering and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to speak and read English fluently.
- You must live in Ontario, Canada.
- You must have a diagnosis of advanced (stage IV) cancer (solid tumor, sarcoma, endocrine, melanoma, or stage 4 lymphoma) with expected survival of more than 6 months.
- You must be experiencing at least mild symptoms of depression.
- You must agree to avoid certain medications, alcohol, and drugs before and after the treatment sessions, and arrange for someone to drive you home afterward.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called psilocybin, given with therapy, can help people with advanced cancer who are feeling anxious or depressed. You must have a stable cancer and be willing to travel to Houston for treatment.
This trial studies whether psilocybin (with support and therapy) can reduce anxiety in people with advanced cancer. It may help with distress and quality of life, while the study team monitors safety closely.
This study tests whether a drug called psilocybin, combined with supportive talk therapy, can help reduce feelings of hopelessness and loss of meaning in people with advanced cancer. If it works, it could offer a new way to improve emotional well-being during a difficult time.
This trial tests whether psilocybin (a psychedelic drug) can help with severe cancer pain. You may qualify if your pain is high despite strong medications and you are willing to be monitored closely.
This trial tests whether psilocybin-assisted therapy can help caregivers of people with advanced cancer who feel anxious or depressed. It focuses on improving emotional well-being and relationships.
This trial tests if a medicine called psilocybin, given with talk therapy, can safely help people with advanced cancer who feel very demoralized. Demoralization is a deep sense of hopelessness or loss of meaning. The goal is to see if this treatment can improve your emotional well-being.
Hear when a new Advanced Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.